Definitive radiotherapy for squamous carcinoma of the larynx

Otolaryngologic Clinics of North America

Volumn 35, Issue 5, 2002, Pages 1013-1033

  Lee, Ding Jen ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIFOSTINE; PILOCARPINE;

CANCER CONTROL; CANCER STAGING; HUMAN; LARYNX CANCER; LARYNX CARCINOMA; ORGAN PRESERVATION; RADIATION DOSE DISTRIBUTION; REVIEW; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME; VOICE; XEROSTOMIA;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CARCINOMA, VERRUCOUS; COMBINED MODALITY THERAPY; HUMANS; LARYNGEAL NEOPLASMS; LARYNX; NEOPLASM STAGING; RADIOTHERAPY, COMPUTER-ASSISTED;

EID: 0036812473     PISSN: 00306665     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0030-6665(02)00039-7     Document Type: Review

References (60)

1. Million RR, Cassisi NJ. Larynx. In: Million RR, Cassisi NJ, editors. Management of Head and Neck Cancer: A Multidisciplinary Approach. Philadelphia: JB Lippincott; 1984. p. 315-64.
2. Kirchner JA. Staging as seen in serial sections. Laryngoscope 1975;85:1816-21.
3. Micheau C, Luboinski B, Sancho H, et al. Modes of invasion of cancer of the larynx: A statistical, histological, and radio clinical analysis of 120 cases. Cancer 1976;38:346-60.
4. American Joint Committee on Cancer. Manual for Staging of Cancer. 5th Edition. Philadelphia: Lippincott-Raven; 1997. p. 41-6.
5. rd Edition. Philadelphia: Lea and Febiger; 1980. p. 330-63.
6. Harwood AR. Cancer of the larynx. The Toronto experience. J Otolaryngol Suppl. 1982; 11:3-21.
7. Mittal B, Rao DV, Marks JE, et al. Role of radiation in the management of early vocal carcinoma. Int J Radiat Oncol Biol Phys 1983;9:997-1002.
8. Amornmaarn R, Prempree T, Viravathana T, et al. A therapeutic approach to early vocal carcinoma. Acta Radiol Oncol 1985;24:321-5.
9. Mendenhall WM, Parsons JT, Million RR. T1-T2 squamous cell carcinoma of the glottic larynx treated with radiation therapy: Relationship of dose-fraction factors to local control and complications. Int 3 Radiat Oncol Biol Phys 1988;15:1267-73.
10. Wang CC. Carcinoma of the larynx. In: Wang CC, editor. Radiation Therapy for Head and Neck Neoplasms: Indications, Techniques and Results. Chicago: Year Book Medical Publishers, 1983. p. 165-99.
11. Johansen LV, Overgaard J, Hjelam-Hansen M, et al. Primary radiotherapy for T1 squamous cell carcinoma of the larynx: Analysis of 478 patients treated from 1963 to 1985. Int J Radiat Oncol Biol Phys 1990;18:1307-13.
12. Le QT, Fu KK, Kroll S, et al. Influence of time and fractionation on local control of T1,2 glottic carcinoma. Int J Radiat Oncol Biol Phys 1997;39:115-26.
13. Lee JH, Machtay M, Mckenna MG, et al. Radiotherapy with 6-megavolt photons for early glottic carcinoma: Potential impact of extension to the posterior vocal cord. Am J Otolaryngol 2001;22:43-54.
14. Van den Bogaert W, Aostyn F, van der Schueren E. The primary treatment of advanced vocal cord cancer: Laryngectomy or radiotherapy? Int J Radiat Oncol Biol Phys 1983;9:329-34.
15. Karim ABMF, Kralendonk JH, Yap LY, et al. Heterogeneity of stage II glottic carcinoma and its therapeutic implicaions. Int J Radiat Oncol Biol Phys 1987;13:313-7.
16. Howell-Burke D, Peters LJ, Geopfert H, et al. T2 glottic cancer: Recurrence, salvage and survival after definitive radiotherapy. Arch Otolaryngol Head Neck Surg 1990;116:830-5.
17. Nozaki M, Furata M, Murakami Y, et al. Radiation therapy for T1 glottic cancer: Involvement of the anterior commisure. Anticancer Res 2000;20:1121-4.
18. Harwood AR, Beale FA, Cummings BJ, et al. T2 glottic cancer: An analysis of dose-time volume factors. Int J Radiat Oncol Biol Phys 1981;7:1501-5.
19. Harwood AR, Beale FA, Cummings BJ, et al. T3 glottic cancer: An analysis of dose time-volume factors. Int J Radiat Oncol Biol Phys 1980;6:675-80.
20. Kim RY, Mark ME, Salter MM. Early stage glottic cancer: Importance of time-dose fractionation in radiation therapy. Radiology 1992;182:273-5.
21. Schwaibold F, Scariato A, Nunno M, et al. The effect of fraction size on control of early glottic cancer. Int J Radiat Oncol Biol Phys 1988;14:451-4.
22. Blakeslee D, Vaughn CW, Shapshay SM, et al. Excisional biopsy in the selective management of T1 glottic cancer. Laryngoscope 1984;94:488-94.
23. Ossoff RH, Sission GA, Shapshay SM. Endoscopic management of selected early vocal carcinoma. Ann Otol Rhinol Laryngol 1985;94:560-4.
24. Wetmore SJ, Jey JM, Suen JY. Laser therapy for T1 glottic carcinoma of the larynx. Arch Otolaryngol Head Neck Surg 1990;112:853-5.
25. Koufman J. The endoscopic management of early squamous carcinoma of the vocal with the carbon dioxide surgical laser: Clinical experience and proposed sub-classification. Otolaryngol Head Neck Surg 1986;95:531-7.
26. Epstein BE, Lee DJ, Kashima H, et al. Stage TI glottic carcinoma: Results of radiation therapy or laser excision. Radiology 1990;175:567-70.
27. Delsupehe KG, Zink I, Lejaegere M, et al. Voice quality after narrow margin laser cordectomy compared with laryngeal irradiation. Otolaryngol Head Neck Surg 1999; 121:528-33.
28. rd Edition. Chicago: Year Book Medical Publishers, 1997. p. 221-55.
29. Le QT, Takamiya R, Shu HK, et al. Treatment results of carcinoma in situ of the glottis. Arch Otolaryngol Head Neck Surg 2000;126:1305-12.
30. Spayne JA, Warde P, O'Sullivan B, et al. Carcinoma-in-situ of the glottic larynx: Results of treatment with radiation therapy. Int J Radiat Oncol Biol Phys 2001;49:1235-8.
31. Bataini JP, Ennuyer A, Poncet P, et al. Treatment of supraglottic cancer by radical high dose radiotherapy. Cancer 1974;33:1253-62.
32. Wall TJ, Peters LJ, Brown BW, et al. Relationship between lymph node status and primary tumor control probability in tumors of the supraglottic larynx. Int J Radiat Oncol Biol Phys 1895;11:1985-2002.
33. Mendenhall WM, Parsons JT, Mancuso AA, et al. Radiotherapy for squamous cell carcinoma of the supraglottic larynx: An alternative to surgery. Head Neck 1996;18:24-35.
34. Overgaard J, Hansen HS, Jorgensen K, et al. Primary radiotherapy of larynx and pharynx carcinoma: An analysis of some factors influencing local control and survival. Int J Radiat Oncol Biol Phys 1986;12:515-21.
35. Garden AS, Morrison WH, Ang KK, et al. Hyperfractionated radiation in the treatment of squamous cell carcinoma of the head and neck: A comparison of two fractionation schedules. Int J Radiat Oncol Biol Phys 1995;31:493-502.
36. Parson JT, Mendenhall WM, Cassisi NJ, et al. Hyperfractionation for head and neck cancer. Int J Radiat Oncol Biol Phys 1988;14:649-58.
37. Fu KK, Pajak TF, Trotti A, et al. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fraction radiotherapy for head and neck squamous carcinoma: First report of RTOG 9003. Int J Radiat Oncol Biol Phys 2000;48:7-16.
38. Mendenhall WM. T3-4 squamous cell carcinoma of the larynx treated with radiation therapy alone. Semin Radiat Oncol 1998;8:262-9.
39. MacKenzie RG, Franssen E, Balough JM, et al. Comparing treatment outcomes of radiotherapy and surgery in locally advanced carcinoma of the larynx: A comparison limited to patients eligible for surgery. Int J Radiat Oncol Biol Phys 2000;47:65-71.
40. Department of Veterans Affairs Laryngeal Cancer Study Group. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med 1991;324:1685-90.
41. Forastiere AA, Berkey B, Maor M, et al. Phase III trial to preserve the larynx: Induction chemotherapy and radiotherapy versus concomitant chemoradiotherapy versus radiotherapy alone, Intergroup trial R91-11. Proceedings of the American Society of Clinical Oncology 2002;20:2a.
42. Vermund H. Role of radiotherapy in cancer of the larynx as related to the TMN system of staging: A review. Cancer 1970;25:485-504.
43. Paisley S, Warde PR, O'Sullivan B, et al. Results of radiotherapy for primary subglottic squamous cell carcinoma. Int J Radiat Oncol Biol Phys 2002;52:1245-50.
44. Ackerman LV. Verrucous carcinoma of the oral cavity. Surgery 1948;23:670-8.
45. Ferlito A, Recher G. Ackerman's tumor (verrucous carcinoma) of the larynx. Cancer 1980; 46:1617-30.
46. O'Sullivan BO, Warde P, Keane T, et al. Outcome following radiotherapy in verrucous carcinoma of the larynx. Int J Radiat Oncol Biol Phys 1995;32:611-7.
47. Kraus FT, Perez-Mesa C. Verrucous carcinoma. Cancer 1966;19:108-15.
48. Schwade JG, Wara WM, Dedo HH, et al. Radiotherapy for verrucous carcinoma. Radiology 1976;120:677-9.
49. Lee DJ, Cosmatos D, Marcial VA, et al. Results of an RTOG Phase III trial (RTOG 85-27) comparing radiotherapy plus etannidazole with radiotherapy alone for locally advanced head and neck carcinomas. Int J Radiat Oncol Biol Phys 1995;32:567-76.
50. Hancock SL, McDougall IR, Constine LS. Thyroid abnormalities after therapeutic external radiation. Int J Radiat Oncol Biol Phys 1995;31:1165-70.
51. Liening DA, Duncan NO, Blakelee DB, et al. Hypothyroidism following radiotherapy form head and cancer. Otolaryngol Head Neck Surg 1990;103:10-3.
52. Johnson JT, Ferretti GA, Nethery WJ, et al. Oral pilocarpine for post-irradiation xerostomia in patients with head and neck cancer. N Engl J Med 1993;329: 390-5.
53. Hariot JC, Lipinski F, Schraub S, et al. Post-radiation severe xerostomia relieved by pilocarpine: A prospective French study. Radiother Oncol 2000;55:233-9.
54. Brizel DM, Wasserman TH, Henk M, et al. Phase III randomized trial of amifostine as a radioprotector in head and neck cancer. J Clin Oncol 2000;18:3339-45.
55. Antonnadou D, Pepelassi M, Synodinou M, et al. Prophylactic use of amifostine to prevent radiochemotherapy-induced mucositis and xerostomia in head and neck cancer. Int J Radiat Oncol Biol Phys 2002;52:739-47.
56. Eisbruch A, Marsh LH, Martel MK, et al. Comprehensive irradiation of head and neck cancer using conformal multisegmental fields: Assessment of target coverage and non-involved tissue sparing. Int J Radiat Oncol Biol Phys 1998;41:559-68.
57. Ling CC, Burman C, Chui CS, et al. Conformal radiation treatment of prostate cancer using inversely-planned intensity modulated photon beams produced with dynamic multileaf collimation. Int J Radiat Oncol Biol Phys 1996;35:721-30.
58. Intensity Modulated Radiation Therapy Collaborative Working Group. Intensity-modulated radiotherapy: Current status and issues of interest. Int J Radiat Oncol Biol Phys 2001;51:880-914.
59. van Dieren EB, Nowak PJCM, Wijers OB, et al. Beam intensity modulation using tissue compensator or dynamic collimation in three-dimensional conformal radiotherapy of primary cancers of the oropharynx and larynx, including the elective neck. Int J Radiat Oncol Biol Phys 2000;47:1299-309.
60. Chao KS, Majhai N, Huang CJ, et al. Intensity-modulated radiation therapy reduces late salivary toxicity without compromising tumor control in patients with oropharyngeal carcinoma: A comparison with conventional techniques. Radiother Oncol 2001;61:275-80.